Oruka Therapeutics Chief Medical Officer Joana Goncalves exercised 7,000 employee stock option and warrant shares on July 15, 2026 at USD 6.84 to USD 7.8.
Goncalves sold 7,000 shares on July 15 at weighted-average prices of about USD 84.37 to USD 87.25.
She ended the day with 32,718 shares of common stock beneficially owned.